BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6943370)

  • 1. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas.
    Holt JA; Lyttle CR; Lorincz MA; Stern SD; Press MF; Herbst AL
    J Natl Cancer Inst; 1981 Aug; 67(2):307-18. PubMed ID: 6943370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progestin binding in cytosols of ovarian adenocarcinomas.
    Holt JA; Caputo TA; Kelly KM; Greenwald P; Chorost S
    Obstet Gynecol; 1979 Jan; 53(1):50-8. PubMed ID: 760018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy.
    Richman CM; Holt JA; Lorincz MA; Herbst AL
    Obstet Gynecol; 1985 Feb; 65(2):257-63. PubMed ID: 3969239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays.
    Press MF; Holt JA; Herbst AL; Greene GL
    Lab Invest; 1985 Sep; 53(3):349-61. PubMed ID: 4033069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.
    Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA
    Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptors in canine mammary tumors.
    MacEwen EG; Patnaik AK; Harvey HJ; Panko WB
    Cancer Res; 1982 Jun; 42(6):2255-9. PubMed ID: 7074608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.
    Pujol P; Rey JM; Nirde P; Roger P; Gastaldi M; Laffargue F; Rochefort H; Maudelonde T
    Cancer Res; 1998 Dec; 58(23):5367-73. PubMed ID: 9850067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear uptake of oestradiol-17 beta in human mammary tumour tissue.
    Thorsen T; Stoa KF
    J Steroid Biochem; 1979 Jun; 10(6):595-9. PubMed ID: 470382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
    Hansen ER; Brooks SC
    Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma.
    Holt JA; Lorincz MA; King WJ
    Obstet Gynecol; 1983 Aug; 62(2):231-5. PubMed ID: 6866366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary.
    Vierikko P; Kauppila A; Vihko R
    Int J Cancer; 1983 Oct; 32(4):413-22. PubMed ID: 6311758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytosol estrogen and progesterone receptors in female genital system malignant tumors].
    Han SW; He B; Tang QP
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):12-5, 59. PubMed ID: 8033616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone and androst-5-ene-3 beta,17 beta-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor.
    Adams JB; Archibald L; Seymour-Munn K
    Cancer Res; 1980 Oct; 40(10):3815-20. PubMed ID: 6449285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
    Pollack A; Irvin GL; Block NL; Lipton RM; Stover BJ; Claflin AJ
    Cancer Res; 1982 Jun; 42(6):2184-90. PubMed ID: 7074599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estradiol receptors in the cytosol of nitrosomethylurea-induced mammary tumors of the rat. Influence of cell nuclei on the cytoplasmic estradiol receptor].
    Dietrich W; Görlich M
    Arch Geschwulstforsch; 1984; 54(1):13-23. PubMed ID: 6703860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncharged nuclear receptors for estrogen in breast cancers.
    Panko WB; MacLeod RM
    Cancer Res; 1978 Jul; 38(7):1948-51. PubMed ID: 657133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
    Langdon SP; Gabra H; Bartlett JM; Rabiaz GJ; Hawkins RA; Tesdale AL; Ritchie AA; Miller WR; Smyth JF
    Clin Cancer Res; 1998 Sep; 4(9):2245-51. PubMed ID: 9748145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.